Nuveen, LLC Eliem Therapeutics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Eliem Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 39,034 shares of ELYM stock, worth $160,429. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,034Holding current value
$160,429% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ELYM
# of Institutions
72Shares Held
53.3MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA31.4MShares$129 Million2.09% of portfolio
-
Janus Henderson Group PLC London, X03.18MShares$13.1 Million0.01% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA2.61MShares$10.7 Million3.29% of portfolio
-
Citigroup Inc1.85MShares$7.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.5MShares$6.18 Million0.0% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $109M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...